AK Medical Holdings Limited disclosed in a Next Day Disclosure Return that it bought back 100,000 ordinary shares on 3 September 2026 via the Hong Kong Stock Exchange. The shares were repurchased at a volume-weighted average price of HK$4.9662 each, for a total consideration of HK$0.50 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined by 0.0093 % to 1.08 billion shares, while the treasury-share balance increased to 32.36 million. The overall share count, including treasury shares, remains unchanged at 1.11 billion.

The latest purchase forms part of the buy-back mandate approved on 17 June 2026, which permits repurchases of up to 112.46 million shares. To date, AK Medical has repurchased 47.92 million shares under this mandate, equivalent to 4.25 % of the issued share count on the mandate date.

Under Hong Kong listing rules, the company is restricted from issuing new shares or disposing of treasury shares until 3 October 2026. Management confirmed that all repurchases complied with applicable regulations and that all requisite approvals and filings have been completed.